Kristian is a fearless and resilient business leader with a flair for selling great ideas and building exceptional teams. More than a decade of experience in the cell therapy field has seen him found a successful cell therapy reagents company, as well as license a promising cell therapy product to a large pharma company.

Kristian Tryggvason is founder and CEO of Alder Therapeutics. He is responsible for driving preclinical development of the company’s promising pipeline of pluripotent stem cell therapies, in addition to managing all PR, marketing and fundraising activities. 

Kristian is a deeply experienced, fearless, and resilient business leader with a flair for selling great ideas and building exceptional teams. Prior to Alder, Kristian founded Swedish cell culture solutions company BioLamina, growing it to a profitable €100m enterprise with 70+ employees and more than €17m in annual sales across 35 countries. He has also held business development and project management positions in the pharmaceutical sector, where he created patent strategies, out-licensed cell therapy products, and gained broad exposure to the clinical, regulatory, and commercial aspects of drug development.

Just like the other members of the Alder Team, Kristian blends his deep business knowledge and experience with rigorous scientific training. He holds an MSc in Molecular Biology from the University of Oulu in Finland, a Ph.D. in Cellular and Molecular Biology from the Karolinska Institute in Sweden, and an MBA from the Copenhagen Business School.